Because the luciferase fragments are inactive separately, productive reconstitution requires them to be brought into sufficient proximity by the tested protein association. Once reconstituted, substrate-dependent light generation converts that molecular event into a measurable signal. Comparing luminescence across conditions can therefore indicate relative interaction strength or changes in interaction dynamics, rather than merely showing that two proteins are present.
Mutations, cellular conditions, and candidate compounds can change the luminescence readout by altering the association between the tested proteins. A reduced signal may be consistent with weakened interaction or disrupted proximity, whereas an increased signal may indicate stabilization. The assay therefore supports controlled comparisons of variants or treatments, with readouts interpreted as changes in the reported association.
Running the assay in living cells preserves a cellular setting for examining interactions and signaling-related changes, whereas a biochemical system provides a noncellular context for testing the association. This distinction affects the question being asked: cell-based measurements can reflect changes under cellular conditions, while biochemical measurements focus on the interaction within the prepared system.
A typical workflow begins by attaching complementary luciferase fragments to the proteins of interest, then examining the tested pair in living cells or a biochemical system. After the proteins are allowed to associate, the luciferase substrate is added and emitted luminescence is measured. Readouts can then be compared across interaction, mutation, condition, or compound experiments.
Candidate compounds can be evaluated by asking whether they change the light signal associated with a protein pair. A lower readout can support investigation of an interaction-disrupting effect, while a higher readout can support testing for stabilization. Because the assay reports association through luminescence, compound comparisons connect molecular treatment to a quantitative interaction outcome.
In biology, the assay can address which proteins associate, how signaling-related interactions change, and how a candidate treatment affects a pathway-associated relationship. It can also support interaction mapping and pathway analysis by converting condition-specific measurements into comparable luminescence values, helping researchers examine molecular associations across different experimental settings.